Jonathan Gabai is a New York, New York based Dentist who is specialized in Dentistry. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Jonathan Gabai is DDS105689 for Dentistry in California. His current practice location is 433 1st Ave, New York. Patients can reach him at 212-998-9818.
Jonathan Gabai is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Jonathan Gabai speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Jonathan Gabai
Specialization:
Dentist
Gender:
Male
Accepts Medicare Assignment:
No
Practice Address:
433 1st Ave, New York, New York, 10010-4067
Phone:
212-998-9818
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1619571668
NPI Enumeration Date:
30 Nov, 2020
NPI Last Update On:
30 Nov, 2020
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jonathan Gabai are as mentioned below.
License Number
Specialization
State
Status
DDS105689
Dentistry
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
433 1st Ave, New York, New York
Zip:
10010-4067
Patients can reach Jonathan Gabai at 433 1st Ave, New York, New York or can call to book an appointment on 212-998-9818. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.